The evidence justifying immunosuppression therapy in multiple sclerosis.
作者信息
Mertin J
出版信息
Proc R Soc Med. 1977 Dec;70(12):871-4. doi: 10.1177/003591577707001214.
Abstract
摘要
相似文献
1
The evidence justifying immunosuppression therapy in multiple sclerosis.支持在多发性硬化症中进行免疫抑制治疗的证据。
Proc R Soc Med. 1977 Dec;70(12):871-4. doi: 10.1177/003591577707001214.
2
[Use of antilymphocyte globulin in autoimmune nervous system diseases].[抗淋巴细胞球蛋白在自身免疫性神经系统疾病中的应用]
Folia Haematol Int Mag Klin Morphol Blutforsch. 1979;106(1):53-64.
3
[Immunological aspects in multiple sclerosis. I. Lymphocyte subpopulations and antilymphocyte antibodies].
Rev Paul Med. 1987 May-Jun;105(3):134-40.
4
[Antilymphocyte globulin in intensive immunosuppression in patients with multiple sclerosis].
Postepy Hig Med Dosw. 1978 Jul-Aug;32(4):513-22.
5
[Current status of the problem of disseminated sclerosis].[播散性硬化症问题的现状]
Klin Med (Mosk). 1985 Sep;63(9):12-9.
6
[Immunosuppressive treatment im multiple sclerosis].[多发性硬化症的免疫抑制治疗]
Fortschr Med. 1980 Oct 2;98(37):1431-6.
7
Autoimmune aspects of demyelinating diseases.脱髓鞘疾病的自身免疫方面
Immunol Ser. 1990;52:155-67.
8
New treatments for multiple sclerosis.多发性硬化症的新疗法。
Br J Hosp Med. 1980 Jan;23(1):63-4, 66, 68.
9
Immunological aspects of multiple sclerosis.多发性硬化症的免疫学方面。
Br J Hosp Med. 1977 Nov;18(5):467-8, 470, 473-6.
10
[Immunosuppressive treatment of multiple sclerosis].
Nervenarzt. 1976 Jul;47(7):424-8.
引用本文的文献
1
Immune-cell crosstalk in multiple sclerosis.多发性硬化症中的免疫细胞串扰
Nature. 2018 Nov;563(7730):194-195. doi: 10.1038/d41586-018-07063-z.
2
Azathioprine in multiple sclerosis--a 3 year controlled study of its effectiveness.硫唑嘌呤治疗多发性硬化症——一项关于其疗效的3年对照研究
J Neurol. 1980;223(2):97-117. doi: 10.1007/BF00313173.
本文引用的文献
1
Effect of 'maximum immune suppression' with thoracic duct drainage, ALG, azathioprine and cortisone in some neurological disorders.胸导管引流、抗淋巴细胞球蛋白、硫唑嘌呤及可的松联合应用达到“最大免疫抑制”对某些神经系统疾病的影响。
Proc R Soc Med. 1972 Jun;65(6):531-5. doi: 10.1177/003591577206500615.
2
Cellular hypersensitivity to basic myelin (A1) protein and clinical multiple sclerosis.细胞对碱性髓鞘（A1）蛋白的超敏反应与临床多发性硬化症。
N Engl J Med. 1974 Jul 4;291(1):14-7. doi: 10.1056/NEJM197407042910104.
3
Double-blind trial of linoleate supplementation of the diet in multiple sclerosis.饮食中补充亚油酸对多发性硬化症的双盲试验。
Br Med J. 1973 Mar 31;1(5856):765-8. doi: 10.1136/bmj.1.5856.765.
4
Evaluation of antithymocyte globulin in acute relapses of multiple sclerosis.
Neurology. 1974 Jan;24(1):34-40. doi: 10.1212/wnl.24.1.34.
5
Multiple sclerosis: an immunologic reassessment.多发性硬化症：免疫学再评估。
J Chronic Dis. 1973 Mar;26(3):119-26. doi: 10.1016/0021-9681(73)90085-4.
6
Cooperative study in the evaluation of therapy in multiple sclerosis. ACTH vs. placebo--final report.多发性硬化症治疗评估的合作研究。促肾上腺皮质激素与安慰剂——最终报告。
Neurology. 1970 May;20(5):1-59. doi: 10.1212/wnl.20.5_part_2.1.
7
Recurrent experimental allergic encephalomyelitis in the Lewis rat.Lewis大鼠复发性实验性变应性脑脊髓炎
J Immunol. 1974 Aug;113(2):712-5.
8
Interference between anti-HLA antibodies and chlorpromazine.抗人白细胞抗原抗体与氯丙嗪之间的干扰
Nature. 1976 Apr 8;260(5551):532-3. doi: 10.1038/260532a0.
9
Intensive immunosuppression in patients with disseminated sclerosis. I. Clinical response.弥漫性硬化症患者的强化免疫抑制。I. 临床反应。
Clin Exp Immunol. 1975 Jul;21(1):1-12.
10
Intensive immunosuppression in patients with disseminated sclerosis. III. Lymphocyte response in vitro.弥漫性硬化症患者的强化免疫抑制。III. 体外淋巴细胞反应
Clin Exp Immunol. 1975 Jul;21(1):23-31.
Zotero 插件